Nobel Prize Winners’ Discovery has Implications for Pain Treatments


Image Credit: Pixabay (Pexels)

Nobel Prize: How Chili Peppers Helped Researchers Uncover How Humans Feel Pain

 

Think about how often we feel a touch, or sense temperature. Perhaps it’s the warmth we feel when we hold a coffee cup or the comfort we feel when hugging a loved one – these sensations are integral to our everyday lives and how we interact with our world. These sensations are all part of our somatosensory system, which is responsible for many different sensations – including temperature, touch, body position and movement, pain and itch. Some might say that the combined effects of our somatosensory system are the very essence of what it is to connect to the world around us and to experience it.

But until the late 1990s, little was known about how the body actually senses temperature and pressure. This is why the 2021 Nobel prize in physiology or medicine was jointly awarded to David Julius and Ardem Patapoutian, whose independent research uncovered the receptors which allow us to sense touch and temperature.

 

This article was republished with permission from  The Conversation, a news site dedicated to sharing ideas from academic experts. It represents the research-based findings and thoughts of  
Francis McGlone, Professor in Neuroscience, Liverpool John Moores University

 

The discoveries made by Julius and Patapoutian help solve questions many people have been asking for years – showing us how these stimuli are converted into nerve signals at a molecular level. These discoveries may also have important implications for developing treatments for a variety of different conditions, including chronic pain, in the future.

 

 

A Bit of Spice

Both researchers began working on this topic in the 1990s but were looking at it in different ways. Julius and his colleagues at the University of California were looking at a rather unconventional compound known as capsaicin, which is the chemical that causes the burning sensation we feel when we touch or eat chili peppers. While researchers already knew capsaicin activated nerve cells that caused pain sensations, Julius sought to uncover which sensors in the nerve endings actually respond to the heat from this compound.

Using lab-grown neurons – humans nerve cells – Julius and his team created a library of millions of DNA strands that corresponded to genes in the sensory neurons that react to pain, heat, and touch. This eventually led them to identify a single gene that was responsible for making cells sensitive to capsaicin. The gene allows cells to build a protein called TRPV1 which leads to these receptors perceiving the heat from capsaicin as painful.

This was the first of many more temperature-sensing receptors Julius and his lab discovered. Using menthol, Julius identified TRPM8, a receptor shown to be activated by cold. He also used the chemical found in wasabi to identify TRPA1, which is triggered by pain. Julius’s TRPV1 discovery was a breakthrough that allowed further research into how temperature induces electrical signals in the nervous system.

 

 Their discoveries may lead to new treatments for managing pain.

 

Patapoutian, from the Scripps Research Institute in California, uncovered the mechanisms which underpin our sense of touch. Patapoutian’s research first began when he and his team identified a type of cell that gave off an electrical signal when it was poked with a micropipette. But to understand more about these pressure-sensitive cells, Patapoutian and his team first needed to identify which receptor was responsible.

They started with 72 candidate genes, inactivating them one by one until they found that the single gene responsible for creating the protein which responds to pressure on cell membranes – known as Piezo1. This discovery then led them to find a second gene, called Piezo2, which functions similarly.

This decades-long search now means researchers understand the mechanisms underpinning our sense of touch. Piezo1 and Piezo2 both work to initiate an electrical signal that travels between cells and to the brain when our skin or internal organs are touched or feel pressure.

 

The Importance of These Senses

Mammals are the only organisms that have the ability to generate and maintain our internal body temperature. If our blood temperature falls below 27? we’re in critical condition. It’s essential for survival to be able to sense temperature changes in our environment in order to maintain our core body temperature. It tells us that we should put a coat on if it’s cold outside, or not to touch a hot stove door so we don’t get hurt.

Julius’s discovery of the temperature-sensitive receptors in our nerves means we now know how changes in our environment’s temperature is detected. Discovering both the receptors that detect heat – TRPV1 – and cold – TRPM8 – now means we may have targets for drugs to treat inflammation, itch, pain, and cold allodynia (increased sensitivity to cold temperatures).

Our sense of touch is also extremely important to us for a number of reasons – not least of which is because it allows us to enjoy a hug. Being able to detect a mechanical stimulus – the sense we call touch – is important to every tissue and cell in our body. It means that the body can monitor blood flow, a full stomach, or when our bladder is full.

Patapoutian’s research means that we now understand which receptors allow us to sense touch, which could have many implications for future treatments. Researchers are already targeting the proteins Patapoutian discovered for the treatment of pain conditions.

 

Suggested Reading:



Opportunities in the Rapidly Growing Pain Management Sector



Stem Cells Role in the Anti-Aging Business





Therapeutic Research Advanced by Stem Cell Science



Improving Mortality Rates Through Genetic Research

 

Stay up to date. Follow us:

 

Global Regulators Release Principles for Financial Market Infrastructures to Stablecoin


Image Credit: Wes Levitt (Theta Labs)

Stablecoin’s Giant Leap Forward Toward Global Adoption

 

Formal guidance on stablecoin arrangements from two international financial authorities has just been released. The guidance is largely seen as positive news for the cryptocurrencies that peg their value to more traditional monetary benchmarks. In a 22-page report that is the result of the G7, G20 and the Financial Stability Board (FSB) request from the Bank for International Settlements (BIS) and the International Organization of Securities Commissions (IOSCO), uniform principles and priorities were outlined.

Overall, the report titled, “Application of the
Principles for Financial Market Infrastructures to Stablecoin Arrangements
” favors rules that follow all relevant principles that guide other monetary systems.  It provides guidance on the topics of Governance, Risk Management, and Settlements.

Governance

In the category of governance, the authors of the guidance believe a stablecoin asset should consider the assets ownership structure and operation while allowing for clear and direct lines of responsibility and accountability. For example, it should be owned and operated by one or more identifiable and responsible legal entities that are ultimately controlled by individuals. The accountable individual(s) responsible for a stablecoins structure and operation will provide adherence to all rules of governance and other related functions.

 

Risk Management

A stablecoin asset operation should regularly review the material risks that the financial market infrastructure (FMI) could pose. It should oversee its function as well as critical entities such as, settlement banks, liquidity providers, transfer operations, and other service providers.  The stablecoin should develop appropriate risk-management frameworks and tools identify and address these risks. Of particular importance, it should identify and implement appropriate risk-reductions, from an integrated and comprehensive view of the entire stablecoin environment.

 

Settlement Finality

An active stablecoin should provide clear and final settlement, regardless of the settlement method used. The stablecoin should clearly define the point at which a transfer on the ledger becomes irrevocable and technical settlement happens and make it transparent whether and to what extent there could be a misalignment between technical settlement and legal finality.  The stablecoin should also ensure proper transparency regarding mechanisms for reconciling any misalignment between technical settlement and legal finality. Standard measures should be in place to resolve the potential losses that could be created in case of reversals stemming from misalignment between technical settlement and legal finality.

 

Money Settlements

Money settlements should have little or no credit or liquidity risk. In assessing the risk presented by the stablecoin, the operator should consider whether the coin provides its holders with a direct legal claim on the issuer and/or claim on, title to or interest in the underlying reserve asset for timely convertibility at par into other liquid assets. It should have a clear process for fulfilling holders’ claims in both normal environments and those that are more stressed.

Credit and liquidity risks of the stablecoin should be controlled so its uses for money settlements are minimized and controlled so that stablecoin is an acceptable alternative to the use of central bank money.

 

Take-Away

The payments landscape is undergoing rapid transformation. While there is no roadmap for any new payment method, international overseers and regulators are trying to devise a workable and uniform framework so developers and operators can devise their currencies to adhere to certain principles and standards.

The consultative report, requested by powerful world groups, will allow stablecoin assets providers to have a basis for design that will assure uniformity and potentially greater acceptance.

 

Do You Know a Student Interested in This Year’s College
Challenge?

 

Suggested Reading:



SPAC Places “Hard Circle” Around Stablecoin Company



Crypto’s Ancillary Businesses as an Opportunity for Investors

 

Sources:

https://www.thetatoken.org/

https://www.iosco.org/library/pubdocs/pdf/IOSCOPD685.pdf

https://www.reuters.com/article/crypto-currency-stablecoins-regulator/stablecoins-to-face-same-safeguards-as-traditional-payments-idUSL8N2R11HX

https://www.barrons.com/articles/stablecoins-just-got-a-step-closer-to-global-regulation-51633522382?mod=hp_INTERESTS_economy-and-policy&refsec=hp_INTERESTS_economy-and-policy

QuickChek – October 6, 2021



PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer

PDS Biotechnology announced that Matthew Hill will join PDS Biotech as its Chief Financial Officer (CFO) effective as of October 18, 2021, to lead the company’s financial strategy through its next phase of growth

Research, News & Market Data on PDS Biotech

Watch recent presentation from PDS Biotech



ACCO Brands Corporation Announces Third Quarter 2021 Earnings Webcast

ACCO Brands Corporation announced that it will release its third quarter 2021 earnings after the market close on October 26, 2021

Research, News & Market Data on ACCO Brands

Watch recent presentation from ACCO Brands



Voyager Digital Business Update for the Quarter Ended September 30, 2021

Voyager Digital announced preliminary revenue and user metrics for the fiscal 2022 first quarter ended September 30, 2021

Research, News & Market Data on Voyager Digital

Watch recent presentation from Voyager Digital



Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza

Cocrystal Pharma announced receipt of clearance from an Australian Human Research Ethics Committee (HREC) to initiate a Phase 1 trial with its orally administered PB2 inhibitor CC-42344 for the treatment of pandemic and seasonal influenza A

Research, News & Market Data on Cocrystal Pharma

Watch recent presentation from Cocrystal Pharma

 

Stay up to date. Follow us:

 

Release – PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer


PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer

 

FLORHAM PARK, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Matthew Hill will join PDS Biotech as its Chief Financial Officer (CFO) effective as of October 18, 2021, to lead the company’s financial strategy through its next phase of growth.

Mr. Hill brings more than 25 years of experience in finance and operational leadership roles for life science companies. He is joining PDS Biotech after spending the last several years at Strata Skin Sciences (Nasdaq: SSKN) as their Chief Financial Officer, where he led the financial vision and strategy for the medical device company. Prior to joining Strata Skin Sciences, he held CFO roles at several companies, including Velcera prior to its acquisition by the Perrigo Company, and EP Medsystems prior to its acquisition by St. Jude Medical, where he also served as the VP of Operations. Mr. Hill holds a Bachelor of Science in accounting from Lehigh University.  

“Given the promise of the Versamune® platform in oncology, I’m excited to bring my experience with life science companies to PDS Biotech’s next chapter. PDS has achieved significant milestones in the last year and I am energized to contribute my expertise and leadership to direct PDS Biotech’s financial strategy to facilitate its next phase of growth,” said Hill.

“We are focused on developing and commercializing novel and more effective treatments for cancer,” said PDS Biotech President and CEO Dr. Frank Bedu-Addo. “Matt’s extensive experience with growth-stage healthcare and life science companies will provide PDS Biotech with solid financial leadership and I look forward to working closely with Matt to fulfill the promise demonstrated thus far of bringing novel oncology products to the market.”

Mr. Hill will replace Seth Van Voorhees in the role of CFO.   Dr. Bedu-Addo continued, “On behalf of our board of directors, we would like to thank Seth for his service to the company and wish him continued success in his future endeavors.”

About PDS Biotechnology

PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline of cancer immunotherapies based on the Company’s proprietary Versamune® T-cell activating technology platform. Our Versamune®-based products have demonstrated the potential to overcome the limitations of current immunotherapy by inducing in vivo, large quantities of high-quality, highly potent polyfunctional tumor specific CD4+ helper and CD8+ killer T-cells. PDS Biotech has developed multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize diseased cells and effectively attack and destroy them. The company’s pipeline products address various cancers including breast, colon, lung, prostate and ovarian cancers.   To learn more, please visit www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the “Company”) and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Company’s management, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” “forecast,” “guidance”, “outlook” and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company’s ability to protect its intellectual property rights; the Company’s anticipated capital requirements, including the Company’s anticipated cash runway and the Company’s current expectations regarding its plans for future equity financings; the Company’s dependence on additional financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Company’s operations or require the Company to relinquish rights to the Company’s technologies or product candidates; the Company’s limited operating history in the Company’s current line of business, which makes it difficult to evaluate the Company’s prospects, the Company’s business plan or the likelihood of the Company’s successful implementation of such business plan; the timing for the Company or its partners to initiate the planned clinical trials for PDS0101, PDS0203 and other Versamune® based products; the future success of such trials; the successful implementation of the Company’s research and development programs and collaborations, including any collaboration studies concerning PDS0101, PDS0203 and other Versamune® based products and the Company’s or monitoring committees’ or other third parties’ interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to support the future success of the Company’s product candidates; the success, timing and cost of the Company’s ongoing clinical trials and anticipated clinical trials for the Company’s current product candidates, including statements regarding the timing of initiation, pace of enrollment, significance of milestones, and completion of the trials (including our ability to fully fund our disclosed clinical trials, which assumes no material changes to our currently projected expenses), futility analyses, presentations at conferences and data reported in an abstract, and receipt of interim results, which are not necessarily indicative of the final results of the Company’s ongoing clinical trials; any Company statements about its understanding of product candidates mechanisms of action and interpretation of preclinical and early clinical results from its clinical development programs and any collaboration studies; the acceptance by the market of the Company’s product candidates, if approved; the timing of and the Company’s ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, the Company’s product candidates; and other factors, including legislative, regulatory, political and economic developments not within the Company’s control, including unforeseen circumstances or other disruptions to normal business operations arising from or related to COVID-19. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Company’s annual and periodic reports filed with the SEC. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Media & Investor Relations Contact:

Deanne Randolph
PDS Biotech
Phone: +1 (908) 517-3613
Email: drandolph@pdsbiotech.com

Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
Email: rich@cg.capital

Release – ACCO Brands Corporation Announces Third Quarter 2021 Earnings Webcast


ACCO Brands Corporation Announces Third Quarter 2021 Earnings Webcast

 

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its third quarter 2021 earnings after the market close on October 26, 2021. The Company will host a conference call and webcast to discuss the results on October 27 at 8:30 a.m. EDT. The webcast can be accessed through the Investor Relations section of www.accobrands.com and will be available for replay.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman
Investor Relations
(847) 796-4320

Julie McEwan
Media Relations
(937) 974-8162

Source: ACCO Brands Corporation

Release – Voyager Digital Business Update for the Quarter Ended September 30, 2021

 


Voyager Digital Business Update for the Quarter Ended September 30, 2021

 

NEW YORKOct. 6, 2021 /CNW/ – Voyager Digital Ltd. (“Voyager” or the “Company”) (TSX: VOYG) (OTCQX: VYGVF) (FRA: UCD2) one of the fastest-growing, publicly traded cryptocurrency platforms in the United States, today announced preliminary revenue and user metrics for the fiscal 2022 first quarter ended September 30, 2021.

“As we exit September and reflect on the growth of our platform, we are glad to report that our Company is stronger than ever,” said Stephen Ehrlich, CEO and Co-founder of Voyager. “Our marketing efforts are contributing to consistent user growth, and we’ve seen trading volume rebound following the general industry-wide downtrend witnessed in July. With international expansion and new products on the horizon, we’re more excited than ever about Voyager’s future and are positioned to operate within applicable regulatory frameworks.”

“As we continue to grow our funded accounts, Voyager’s transactional volume is contingent on market volume and the overall market volume decreased substantially in July and August. We have begun to diversify our revenue model to generate long term staking rewards providing recurring revenue. As we continue to develop staking capabilities, we expect that reward and yield revenue will generate a minimum of $40 – $50 million of rewards and yield revenue for the December quarter in addition to the standard transactional revenue,” added Mr. Ehrlich.

The Company is pleased to announce the following fiscal 2022 first quarter ended September 30, 2021 Financial and Operational Key Metrics:

  • Total funded accounts exceed 860,000, up 29% from 665,000 at fiscal year ended June 30, 2021
  • Total verified users on the platform now stand at more than 2.15 million, up 23% from 1.75 million at fiscal year ended June 30, 2021
  • Preliminary revenue for the quarter is estimated at $63 – 67 million, compared to $109 million for the fiscal fourth quarter ended June 30, 3021
  • Net new deposits were approximately $827 million, compared to the $1,620 million for the fiscal fourth quarter ended June 30, 2021

Sept 30, 2021

June 30, 2021

Sept 30, 2020

Revenues (millions)

$63 to $67 (1)

$109 (2)

$2

Total Funded Accounts

860,000

665,000

23,400

Total Verified Users

2,150,000

1,750,000

87,500

Net New Deposits (millions)

$827

$1,620

$36



(1)

preliminary and unaudited and subject to final adjustment.

(2)

unaudited

All amounts are in U.S. dollars, unless otherwise indicated.

About Voyager Digital Ltd.
Voyager Digital Ltd. (TSX: VOYG; OTCQX: VYGVF; FRA: UCD2) is a fast-growing, publicly traded cryptocurrency platform in the United States founded in 2018 to bring choice, transparency, and cost efficiency to the marketplace. Voyager offers a secure way to trade over 60 different crypto assets using its easy-to-use mobile application, and earn rewards up to 12 percent annually on more than 30 cryptocurrencies. Through its subsidiary Coinify ApS, Voyager provides crypto payment solutions for both consumers and merchants around the globe. To learn more about the company, please visit https://www.investvoyager.com.

The TSX has not approved or disapproved of the information contained herein.

Financial Disclaimer:
The preliminary estimated financial results and other data for the three months ended September 30, 2021 set forth above are subject to the completion of the Company’s financial closing procedures. This data has been prepared by, and is the responsibility of, the Company’s management and audit committee. Voyager’s independent registered public accounting firm, Marcum LLP, does not express an opinion or any other form of assurance with respect thereto. The Company currently expects that its final results of operations and other data for the interim period ended September 30, 2021 will be consistent with the estimates set forth above, but such estimates are preliminary and Voyager’s actual results of operations and other data could differ materially from these estimates due to the completion of its quarterly review procedures, final adjustments, and other developments that may arise between now and the time such unaudited consolidated financial statements for the three months ended September 30, 2021 are released.

Forward Looking Statements
Certain information in this press release, including, but not limited to, statements regarding future growth and performance of the business, momentum in the businesses, future adoption of digital assets, and the Company’s anticipated results may constitute forward looking information (collectively, forward-looking statements), which can be identified by the use of terms such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue” or “believe” (or the negatives) or other similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Voyager’s actual results, performance or achievements to be materially different from any of its future results, performance or achievements expressed or implied by forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Forward looking statements are subject to the risk that the global economy, industry, or the Company’s businesses and investments do not perform as anticipated, that revenue or expenses estimates may not be met or may be materially less or more than those anticipated, that trading momentum does not continue or the demand for trading solutions declines, customer acquisition does not increase as planned, product and international expansion do not occur as planned, risks of compliance with laws and regulations that currently apply or become applicable to the business or the interpretation or application of laws and regulations by regulatory authorities, and those other risks contained in the Company’s public filings, including in its Management Discussion and Analysis and its Annual Information Form (AIF). Factors that could cause actual results of the Company and its businesses to differ materially from those described in such forward-looking statements include, but are not limited to, a decline in the digital asset market or general economic conditions; changes in laws or approaches to regulation, the failure or delay in the adoption of digital assets and the blockchain ecosystem by institutions; changes in the volatility of crypto currency, changes in demand for Bitcoin and Ethereum, changes in the status or classification of cryptocurrency assets, cybersecurity breaches, a delay or failure in developing infrastructure for the trading businesses or achieving mandates and gaining traction; failure to grow assets under management, an adverse development with respect to an issuer or party to the transaction or failure to obtain a required regulatory approval. In connection with the forward-looking statements contained in this press release, the Company has made assumptions that no significant events occur outside of the Company’s normal course of business and that current trends in respect of digital assets continue. Readers are cautioned that the key metrics disclosed in this press release, including, without limitation,  Assets Under Management and trading volumes fluctuate and may increase and decrease from time to time and that such fluctuations are beyond the Company’s control. Forward-looking statements, past and present performance and trends are not guarantees of future performance, accordingly, you should not put undue reliance on forward-looking statements, current or past performance, or current or past trends. Information identifying assumptions, risks, and uncertainties relating to the Company are contained in its filings with the Canadian securities regulators available at www.sedar.com. The forward-looking statements in this press release are applicable only as of the date of this release or as of the date specified in the relevant forward-looking statement and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after that date or to reflect the occurrence of unanticipated events. The Company assumes no obligation to provide operational updates, except as required by law. If the Company does update one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements, unless required by law. Readers are cautioned that past performance is not indicative of future performance and current trends in the business and demand for digital assets may not continue and readers should not put undue reliance on past performance and current trends.  All figures are in U.S. dollars unless otherwise noted.

Press Contacts

Voyager Digital, Ltd.
Michael Legg
Chief Communications Officer
(212) 547-8807
mlegg@investvoyager.com

Voyager Public Relations Team
pr@investvoyager.com

SOURCE Voyager Digital (Canada) Ltd.

Related Links

https://www.investvoyager.com/

Release – Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza


Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza

 

BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of coronaviruses, influenza, hepatitis C viruses and noroviruses, announces receipt of clearance from an Australian Human Research Ethics Committee (HREC) to initiate a Phase 1 trial with its orally administered PB2 inhibitor CC-42344 for the treatment of pandemic and seasonal influenza A.

The Phase 1 randomized, double-blind, placebo-controlled study is expected to enroll 56 healthy volunteers at a single site in Australia. The study is designed to assess the safety, tolerability and pharmacokinetics of CC-42344.

CC-42344 binds to a highly conserved PB2 site of influenza polymerase complex and exhibits a novel mechanism of action that inhibits viral replication. In preclinical testing, CC-42344 demonstrated excellent antiviral activity against influenza A strains, including avian pandemic strains and Tamiflu® and Xofluza®-resistant strains, as well as favorable pharmacokinetic and drug-resistance profiles.

“The need for a novel, broad-spectrum, oral antiviral for pandemic and seasonal influenza A is clear as current approved influenza treatments are partially effective and are prone to viral resistance,” said Sam Lee, Ph.D., Cocrystal’s President and co-interim CEO. “We discovered CC-43244 using our proprietary structure-based drug discovery platform technologies. CC-43244 is specifically designed to be effective against pandemic and seasonal influenza A strains and emerging avian influenza viruses.”

“Our decision to conduct the Phase 1 trial in Australia was due to favorable regulatory policies and a clinical trial environment that aligns with our strategy for rapid, cost-efficient and high-quality clinical development,” added James Martin, Cocrystal’s CFO and co-interim CEO. “We are delighted to begin our first clinical study with CC-42344 as a treatment for this major global health concern.”

The World Health Organization (WHO) estimate there are approximately 1 billion cases of influenza annually worldwide, resulting in 3 million to 5 million cases of severe illness and 290,000 to 650,000 deaths. The Center for Disease Control (CDC) estimates that since 2010 influenza has resulted in 9 million to 45 million illnesses in the U.S. annually, resulting in 140,000 to 810,000 hospitalizations and 12,000 to 61,000 deaths.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of coronaviruses (including SARS-CoV-2), influenza viruses, hepatitis C virus and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding conducting the Phase 1 study of CC-42344 in Australia and our strategy with respect to clinical development. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events. Some or all of the events anticipated by these forward-looking statements may not occur. Important factors that could cause actual results to differ from those in the forward-looking statements include, but are not limited to, the risks and uncertainties arising from the impact of the COVID-19 pandemic on the national and global economy, on our collaboration partners, CROs, CMOs, and on our Company, including raw material and test animal shortages and other supply chain disruptions, the ability of our CROs to recruit volunteers for, and to proceed with, clinical trials, possible delays resulting from the lockdowns in Australia, potential delays related to the manufacturing of the drug for the study, the results of clinical trials, general risks arising from clinical trials, receipt of regulatory approvals, regulatory changes, and development of effective treatments and/or vaccines by competitors, including as part of the programs financed by the U.S. government. Further information on our risk factors is contained in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2020. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

Source: Cocrystal Pharma, Inc.

Palladium One Mining (NKORF)(PDM:CA) – Additional Drill Results Released; Board and Management Appointments

Wednesday, October 06, 2021

Palladium One Mining (NKORF)(PDM:CA)
Additional Drill Results Released; Board and Management Appointments

Palladium One Mining Inc is a palladium dominant, PGE, nickel, copper exploration and development company. Its assets consist of the Lantinen Koillismaa and Kostonjarvi PGE-Cu-Ni projects, located in north-central Finland and the Tyko Ni-Cu-PGE and Disraeli PGE-Ni-Cu properties in Ontario, Canada. LK is targeting disseminated sulphide along 38 kilometers of favorable basal contact. The KS project is targeting massive sulphide within a 20,000-hectare land package covering a regional scale gravity and magnetic geophysical anomaly. Tyko is a 13,000-hectare project targeting disseminated and massive sulphide in a highly metamorphosed Archean terrain. Disraeli is a 2,500-hectare project targeting PGE-rich disseminated and massive sulphide in a highly productive Proterozoic mid-continent rift.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Kaukua South drilling results. Palladium One Mining released drill results for six holes at Kaukua South. Hole LK21-088 intersected 3.1 grams of palladium equivalent per tonne over 21.3 meters, within 2.4 grams of palladium equivalent per tonne over 48.5 meters, starting at 120 meters depth. With Hole LK21-087 returning 1.0 gram of palladium equivalent per tonne over 51.0 meters, the mineralized zone of Kaukua South has been extended 200 meters east from previous drilling.

    Potential to add resources along the eastern extension.  The company has focused on including the western two kilometers of Kaukua South into a maiden resource estimate and expanding the initial 2019 Kaukua mineral resource estimate. The eastern portion of Kaukua South has not been drilled extensively despite returning significant results in the past. Hole LK21-087 is the furthest hole drilled to …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Eagle Bulk Shipping (EGLE) – Capital Allocation Shifts to Dividends

Wednesday, October 06, 2021

Eagle Bulk Shipping (EGLE)
Capital Allocation Shifts to Dividends

Eagle Bulk Shipping Inc. is a US-based drybulk owner-operator focused on the Supramax/Ultramax mid-size asset class, which ranges from 50,000 and 65,000 deadweight tons in size; these vessels are equipped with onboard cranes allowing for the self-loading and unloading of cargoes, a feature which distinguishes them from the larger classes of drybulk vessels and provides for greatly enhanced flexibility and versatility- both with respect to cargo diversity and port accessibility. The Company transports a broad range of major and minor bulk cargoes around the world, including coal, grain, ore, pet coke, cement, and fertilizer. Eagle operates out of three offices, Stamford (headquarters), Singapore, and Hamburg, and performs all aspects of vessel management in-house including: commercial, operational, technical, and strategic.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Management call highlighted global refinancing, variable dividend and buy back program. Catalyst for new capital allocation strategy was the global refinancing. Refinancing of high cost 8.25% bonds and all other debt with a new five-year term $300 million loan and a $100 million revolver saves $8 million/year and sets the stage for new variable dividend policy.

    New variable dividend starting this quarter.  Due to higher cash flow and declining financial leverage, a dividend policy will be instituted based on a simple and straightforward percent of net income. Quarterly dividend will equal a minimum of 30% of the previous quarter’s net income with a floor of $0.10/share. First dividend will be based on 3Q2021 results and paid in November. We estimate …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Palladium One Continues to Deliver Strong Drilling Results at Kaukua South Finland


Palladium One Continues to Deliver Strong Drilling Results at Kaukua South, Finland

 

3.1 g/t Palladium Equivalent over 21.3 meters, within 2.4 g/t Palladium Equivalent over 48.5 meters at Kaukua South, LK Project, Finland

Drilling extends mineralization 200 meters on eastern side of Kaukua South, returning 1.0 g/t Palladium Equivalent over 51.0 meters

October 5, 2021 – Toronto, Ontario – Palladium One Mining Inc. (“Palladium One” or the “Company”) (TSXV: PDM, FRA: 7N11, OTC: NKORF) is pleased to announce Kaukua South drillhole LK21-088 intersected 3.1 g/t Palladium Equivalent (“Pd_Eq”) over 21.3 meters, within 2.4 g/t Pd_Eq over 48.5 meters, starting at 120 meters depth (Figure 1, and 2).

Additionally, with hole LK-21-087 returning 1.0 g/t Pd_Eq over 51.0 meters the mineralized zone of Kaukua South has been extended 200 meters east from previous drilling, (Figure 3). In aggregate, the Kaukua Trend which includes both the Kaukua deposit and the Kaukua South Zone, now boasts a drill defined mineralized strike length of 4.4 kilometers within a 7-kilometer-long Induced Polarization (“IP”) chargeability anomaly (Figure 1 and 3). Hole LK21-087 confirms that the eastern portion of the Kaukua Trend remains open for further expansion, particularly given a robust IP anomaly has been identified 1 kilometer east of hole LK21-087, see news release July 7, 2021.

Derrick Weyrauch, President and CEO of Palladium One highlighted: “Our Kaukua South discovery continues to deliver excellent results. Today’s drill results from the eastern portion of the Kaukua Trend is further evidence of a prolific mineralized system on our property which we plan to follow up with additional drilling.”

The eastern portion of Kaukua South has received significantly less drilling as we are focused on brining the western two kilometers of Kaukua South to a maiden Resource Estimate and expanding the initial 2019 Kaukua Mineral Resource Estimate. The eastern portion of Kaukua South has returned significant results in the past, such as hole LK20-017 which returned 1.56 g/t Pd_Eq over 22.2 meters (0.22 g/t Pd, 0.05 g/t Pt, 0.09 g/t Au, 0.32% Cu, 0.20% Ni, 119 ppm Co), see October 22, 2020. Today’s announcement of hole LK21-087, is the furthest step-out hole drilled to the east at Kaukua South which when combined with the strong IP anomalies indicate a strong potential to add additional resources along the eastern extension of the Kaukua Trend.

Figure 1. Historic and current drilling in the Kaukua and Western portion of the Kaukau South area having a drill data cut off date of September 4, 2021 (hole LK21-128), assays have been received for holes up to LK21-088, the rest are pending. Background is Induced Polarization (“IP”) Chargeability.

Figure 2. Kaukua South Long Section. Having a drill data cut off date of September 4, 2021 (hole LK21-128), assays have been received for holes up to LK21-088, the rest are pending. The long section covers only the western portion of Kaukua South which the Company is focused on bringing to an initial NI43-101 resource estimate. The long section is a vertical slice representing only the ~55° south dipping Lower Zone of Kaukua South. Intercepts are represented in both width (meters) and grade (Pd_Eq*) as well as gram*meters (grade*width).

Figure 3. Eastern portion of Kaukua South, showing results for holes LK21-083 through 087.

Table 1. LK Project Kaukua South Drill Hole Results

Hole From
(m)
To
(m)
Width
(m)
Pd_Eq
g/t*
Spot
Cu_Eq
g/t**
Spot
Au_Eq
g/t**
Pd
g/t
Pt
g/t
Au
g/t
Cu
%
Ni
%
Co
ppm
LK21-083 Upper Zone 92.0 106.5 14.5 1.11 0.68 1.12 0.19 0.05 0.07 0.12 0.17 108
Lower Zone 191.0 206.5 15.5 0.92 0.56 0.93 0.34 0.12 0.04 0.08 0.09 68
Inc. 191.0 197.0 6.0 1.69 1.04 1.71 0.79 0.26 0.09 0.13 0.11 72
Inc. 191.8 192.7 0.9 3.89 2.39 3.93 1.81 0.65 0.16 0.31 0.28 135
LK21-084 Upper Zone 78.5 98.0 19.5 0.71 0.44 0.72 0.10 0.03 0.04 0.07 0.11 86
Inc. 78.5 87.5 9.0 0.98 0.60 0.98 0.15 0.04 0.06 0.09 0.16 111
Lower 142.5 148.5 6.0 0.80 0.49 0.81 0.18 0.09 0.04 0.09 0.10 75
LK21-085 Upper Zone 114.7 116.1 1.4 2.37 1.49 2.44 0.00 0.00 0.01 0.71 0.29 424
LK21-086 Upper Zone 79.5 99.0 19.5 1.06 0.65 1.07 0.19 0.04 0.07 0.14 0.15 98
Inc 81.0 88.7 7.7 1.43 0.88 1.44 0.29 0.07 0.09 0.16 0.20 128
lower Zone 172.0 176.0 4.0 0.76 0.46 0.76 0.33 0.15 0.02 0.04 0.06 59
LK21-087 Upper Zone 70.0 121.0 51.0 1.02 0.63 1.04 0.16 0.04 0.06 0.13 0.15 103
Inc 78.0 82.5 4.5 1.56 0.97 1.59 0.32 0.05 0.09 0.20 0.22 135
Lower Zone 230.0 248.0 18.0 0.53 0.33 0.54 0.13 0.05 0.02 0.06 0.07 50
Inc. 230.0 232.0 2.0 1.30 0.79 1.30 0.40 0.18 0.04 0.11 0.15 95
LK21-088 Upper Zone 18.9 84.0 65.1 0.58 0.36 0.59 0.09 0.02 0.04 0.07 0.09 69
Inc. 18.9 42.0 23.1 0.73 0.45 0.74 0.11 0.04 0.05 0.07 0.11 86
Lower Zone 119.5 168.0 48.5 2.36 1.45 2.39 1.21 0.41 0.10 0.17 0.14 76
Inc. 122.2 143.5 21.3 3.12 1.92 3.15 1.57 0.51 0.15 0.23 0.19 99
Inc. 142.0 143.5 1.5 5.63 3.46 5.70 3.23 1.06 0.27 0.37 0.24 91

* Pd_Eq calculated using prices from the 2021 NI43-101 Haukiaho Mineral Resource Estimate; $1,600/oz Pd, $1,100/oz Pt, $1,650/oz Au, $3.50 Cu, and $7.50 Ni
** Spot Au_Eq and Cu_Eq is calculated for comparison only, using recent prices, $1,850/oz Pd, $950/oz Pt, $1750/oz Au, $4.2/lb Cu, and $8.20/lb Ni, and $24/lb cobalt.
Grey Italicised results are previously released (see press release October 22, 2020).

Palladium Equivalent
Revised price assumptions – The Company is now calculating Palladium equivalent using US$1,600 per ounce for palladium, US$1,100 per ounce for platinum, US$1,650 per ounce for gold, US$3.50 per pound for copper, and US$7.50 per pound for nickel consistent with the calculation used in the Company’s September 2021 NI 43-101 Haukiaho Resource Estimate.

Spot Gold Equivalent
Spot palladium and gold equivalents are calculated using recent spot prices for comparison purposes using US$1,850 per ounce for palladium, US$950 per ounce for platinum, US$1,750 per ounce for gold, US$4.2 per pound for copper, and US$8.2 per pound for nickel.

Qualified Person
The technical information in this release has been reviewed and verified by Neil Pettigrew, M.Sc., P. Geo., Vice President of Exploration and a director of the Company and the Qualified Person as defined by National Instrument 43-101

About Palladium One
Palladium One Mining Inc. is an exploration company targeting district scale, platinum-group-element (PGE)-copper nickel deposits in Finland and Canada. Its flagship project is the Läntinen Koillismaa or LK Project, a palladium dominant platinum group element-copper-nickel project in north-central Finland, ranked by the Fraser Institute as one of the world’s top countries for mineral exploration and development. Exploration at LK is focused on targeting disseminated sulfides along 38 kilometers of favorable basal contact and building on an established NI 43-101 open pit Mineral Resource.

ON BEHALF OF THE BOARD
“Derrick Weyrauch”
President & CEO, Director

For further information contact: Derrick Weyrauch, President & CEO
Email: info@palladiumoneinc.com

Neither the TSX Venture Exchange nor its Market Regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release includes “forward-looking information” that is subject to a few assumptions, risks and uncertainties, many of which are beyond the control of the Company. Statements regarding listing of the Company’s common shares on the TSXV are subject to all of the risks and uncertainties normally incident to such events. Investors are cautioned that any such statements are not guarantees of future events and that actual events or developments may differ materially from those projected in the forward-looking statements. Such forward-looking statements represent management’s best judgment based on information currently available. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions and general business conditions. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those set out in the Company’s annual information form dated April 27, 2021 and filed under the Company’s profile on SEDAR at www.sedar.com. The Company does not undertake to update forward-looking statements or forward-looking information, except as required by law. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements.

Release -Palladium One Announces the Appointment of a Board Chairman Chief Financial Officer and ESG Committee


Palladium One Announces the Appointment of a Board Chairman, Chief Financial Officer and ESG Committee

 

October 5, 2021 – Toronto, Ontario – Palladium One Mining Inc. (“Palladium One” or the “Company”) (TSXV: PDM, FRA: 7N11, OTC: NKORF) is pleased to announce the appointment of Mr. Lawrence Roulston as Non-Executive Chairman and Ms. Sara Hills as Chief Financial Officer and Corporate Secretary. In addition, the Company is pleased to announce the formation of a new ESG committee of the board of directors. The ESG Committee, will be chaired by Ms. Giovanna Bee Moscoso an Independent Director of the Company.

“We are delighted to have Mr. Roulston, Ms. Moscoso and Ms. Hills take on their new responsibilities and look forward to gaining from their extensive experiences” said Derrick Weyrauch President and CEO of Palladium One. “We wish to thank Mr. Robert Scott and Mr. Jeff Dare for their, respective, past services as CFO and Corporate Secretary of the Company and we wish them much success in their future endeavors.”

About Lawrence Roulston

Lawrence Roulston is a mining professional with over 35 years of diverse hands-on experience. He heads WestBay Capital Advisors, providing business advisory and capital markets expertise to the junior and mid-tier sectors of the mining industry. From 2014 to 2016, he was President of Quintana Resources Capital, which provided resource advisory services for US private investors. Before Quintana, he was a mining analyst and consultant, as well as the editor of “Resource Opportunities”, an independent investment publication focused on the mining industry. Prior to this, Lawrence was an analyst or executive with various companies in the resources industry, both majors and juniors. He has graduate-level training in business and holds a B.Sc. in geology and is presently a director of Metalla Royalty and Streaming Ltd, Mountain Boy Minerals Ltd, Thunderstruck Resources Ltd and Enduro Metals Corp.

About Giovanna Bee Moscoso

Ms. Bee Moscoso is an experienced mining executive with over 28 years of experience, including progressive responsibilities over 25 years at Barrick Gold Corporation, where previously she was a partner, Vice President and Assistant General Counsel. At Barrick she co-designed and co-led the implementation of the Global Ethics and Compliance Program of Barrick Gold.

Giovanna has managed legal, regulatory, permitting and contractual matters for various mines in the Americas during exploration, development, operations and mine closures, and held responsibilities for coordinating government and public relations, and developing social outreach programs to foster positive relations with stakeholders, including long-term agreements with indigenous communities and private landowners. Her background also includes providing legal and governance oversight to major mining operations in the Americas and Africa.

About Sara Hills

Ms. Hills is a CPA, CA with over 16 years experience in accounting and finance and has achieved increasingly senior roles in public mining companies including with KGHM International and Teck Resources. At KGHM International she led the accounting and financial reporting functions for Quadra Mining and Quadra FNX as well as the international reporting for KGHM International. At Teck Resources she worked closely with the exploration group, leading their accounting, reporting and budgeting functions. She started her career in public practice at BDO and KPMG and holds a BBA.

About Palladium One

Palladium One Mining Inc. is an exploration company targeting district scale, platinum-group-element (PGE)-copper nickel deposits in Finland and Canada. Its flagship project is the Läntinen Koillismaa or LK Project, a palladium dominant platinum group element-copper-nickel project in north-central Finland, ranked by the Fraser Institute as one of the world’s top countries for mineral exploration and development. Exploration at LK is focused on targeting disseminated sulfides along 38 kilometers of favorable basal contact and building on an established NI 43-101 open pit Mineral Resource.

ON BEHALF OF THE BOARD
“Derrick Weyrauch”
President & CEO, Director

For further information contact: Derrick Weyrauch, President & CEO
Email: info@palladiumoneinc.com

Neither the TSX Venture Exchange nor its Market Regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release includes “forward-looking information” that is subject to a few assumptions, risks and uncertainties, many of which are beyond the control of the Company. Statements regarding listing of the Company’s common shares on the TSXV are subject to all of the risks and uncertainties normally incident to such events. Investors are cautioned that any such statements are not guarantees of future events and that actual events or developments may differ materially from those projected in the forward-looking statements. Such forward-looking statements represent management’s best judgment based on information currently available. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions and general business conditions. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those set out in the Company’s annual information form dated April 29, 2020 and filed under the Company’s profile on SEDAR at www.sedar.com. The Company does not undertake to update forward-looking statements or forward-looking information, except as required by law. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements.

Release – Comtech Telecommunications Corp. Declares $0.10 Per Share Quarterly Cash Dividend


Comtech Telecommunications Corp. Declares $0.10 Per Share Quarterly Cash Dividend

 

MELVILLE, N.Y.–(BUSINESS WIRE)–Oct. 4, 2021– 
October 4, 2021— 
Comtech Telecommunications Corp. (NASDAQ: CMTL) announced today that its Board of Directors declared a quarterly cash dividend of 
$0.10 per share, payable on 
November 12, 2021, to shareholders of record at the close of business on 
October 13, 2021. The dividend is the Company’s forty-fifth consecutive quarterly dividend. The Board of Directors is currently targeting fiscal 2022 quarterly dividend payments of 
$0.10 per common share. Future Common Stock dividends remain subject to compliance with financial covenants under the Company’s secured credit facility as well as Board approval.

Comtech Telecommunications Corp. is a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies to commercial and government customers around the world. Headquartered in 
Melville, New York and with a passion for customer success, 
Comtech designs, develops, produces and markets advanced and secure wireless solutions. For more information, please visit www.comtechtel.com.

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s 
Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such 
Securities and Exchange Commission filings.

Media Contact
Kekst CNC
Nicholas.Capuano@kekstcnc.com / Kimberly.Kriger@kekstcnc.com
(212) 521-4800

Investor Contact
Comtech Investor Relations
Investors@comtech.com
(631) 962-7005

Source: 
Comtech Telecommunications Corp.

Release – Comtech Announces Leadership Transition


Comtech Announces Leadership Transition

President and COO Michael Porcelain to become Chief Executive Officer by Calendar Year End

MELVILLE, N.Y.–(BUSINESS WIRE)–Oct. 4, 2021– 
October 4, 2021— 
Comtech Telecommunications Corp. (NASDAQ: CMTL), a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies, announced today that its President and Chief Operating Officer  Michael Porcelain will become Chief Executive Officer, succeeding  Fred Kornberg, by the end of calendar 2021.  Mr. Porcelain will also continue as President of 
Comtech and join its Board of Directors. It is anticipated that  Mr. Kornberg will become an advisor to the Company on technology matters and continue as a director and a non-executive Chairman of the Board.

As a senior technology advisor to the Company,  Mr. Kornberg would assist with the leadership transition and provide the executive team counsel based on his deep technical expertise.

This change completes the Company’s CEO succession plan process initiated by the Board of Directors with its appointment of  Mr. Porcelain as Chief Operating Officer in 2018 and President in 2020.  Mr. Porcelain previously served as the Company’s Chief Financial Officer for more than 12 years and, prior to that, served as Comtech’s Vice President of Finance and Internal Audit from 2002 to 2006. Before joining 
Comtech, he was Director of Corporate Profit and Business Planning for Symbol Technologies (which was subsequently acquired by Motorola) and also served as a Manager in the 
Transaction Advisory Services Group of PricewaterhouseCoopers where he specialized in providing consulting services to both large and small technology companies.

The Board of Directors said: “We want to thank Fred for his outstanding leadership, countless contributions and unwavering commitment to 
Comtech throughout his distinguished career. When Fred first took on the role of CEO of 
Comtech, the Company had less than 
$20.0 million of revenue and approximately 
$1.0 million of net income. Today, 
Comtech is a global leader in its markets, provides innovative solutions to support critical communication systems, and has over 2,000 employees around the world. As we look to the next chapter in Comtech’s history, we want to express our enthusiastic confidence in the future of the company under Mike’s leadership.”

“Mike has been instrumental in the development and execution of our business strategies, leading our day-to-day operations and driving substantial shareholder value creation across all facets of the Company. In the past several years, Mike spearheaded the expansion of both our Next-Generation 911 and satellite earth station product lines, including the transformative acquisitions of 
Solacom Technologies Inc., a best-in-class 911 call handling software solution, 
CGC Technology Limited, a leading provider of Low Earth Orbit (“LEO”) satellite tracking antennas and UHP Networks, a leading provider of disruptive satellite ground station technology. During fiscal 2021, he oversaw the Company’s efforts to secure over 
$200 million of Next-Generation 911 contract wins as well as a strategic multi-year contract award to customize our next-generation broadband satellite technology for use with the thousands of LEO satellites to be launched over the next several years. Mike is highly valued for his exceptional management skills, technical acumen, and understanding of our business and markets, and we are confident in his ability to lead Comtech’s next phase of growth and profitability.”

Mr. Kornberg said: “For more than 40 years, I have had the privilege of leading 
Comtech as we built a global business. I am deeply grateful for the support of our investors over the years and for the steadfast dedication and commitment of our world class employees.”

Mr. Porcelain said, “I am honored to become CEO of 
Comtech. Under Fred’s leadership, we successfully expanded our core capabilities and positioned 
Comtech to respond more quickly to market dynamics. I believe we are extremely well positioned to extend our competitive advantages and enhance value for all stakeholders. I look forward to continuing to work with the Board, management, and the entire 
Comtech team to implement a range of important initiatives already underway and carry our strong momentum forward.”

About Comtech

Comtech Telecommunications Corp. is a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies to commercial and government customers around the world. Headquartered in 
Melville, New York and with a passion for customer success, 
Comtech designs, produces and markets advanced and secure wireless solutions. For more information, please visit www.comtechtel.com.

Forward-Looking Statements

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s 
Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such 
Securities and Exchange Commission filings.

Media Contact
Kekst CNC
Nicholas.Capuano@kekstcnc.com / Kimberly.Kriger@kekstcnc.com
(212) 521-4800

Investor Contact
Comtech Investor Relations
Investors@comtech.com
(631) 962-7005

Source: 
Comtech Telecommunications Corp.